E-submission
THE KOREAN LIVER CANCER ASSOCIATION
Search
- Page Path
- HOME > Search
Review Article
- Clinical Application of Liver Stiffness Measurement for Assessing the Risk of Hepatocellular Carcinoma
- Jeong-Ju Yoo, Eun-Ae Jung, Sang Gyune Kim
- J Liver Cancer. 2019;19(1):12-18. Published online March 31, 2019
- DOI: https://doi.org/10.17998/jlc.19.1.12
- 4,932 Views
- 105 Downloads
- 1 Citation
-
Abstract
PDF - The most significant risk factor for hepatocellular carcinoma (HCC) is the presence of cirrhosis or advanced fibrosis of the liver. Liver biopsy was traditionally considered the gold standard for assessing the liver fibrosis burden. Recently, non-invasive methods, particularly transient elastography (TE), have proven effective at measuring fibrosis and determining cirrhosis. Clinical application of TE ranges from measuring fibrosis to predicting long-term prognosis and treatment response. Here, we focus on recent studies on the prognostic value of TE for predicting HCC.
-
Citations
Citations to this article as recorded by
- Metabolic dysfunction associated fatty liver disease and the risk of hepatocellular carcinoma
Byeong Geun Song, Sung Chul Choi, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Seung Woon Paik
JHEP Reports.2023; : 100810. CrossRef
- Metabolic dysfunction associated fatty liver disease and the risk of hepatocellular carcinoma
First
Prev
Follow JLC on Twitter